BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1152293)

  • 1. The effect of dipyridamole on the coronary hemodynamics in man.
    Tamura K; Honda T; Muto N; Bannai S
    Jpn Heart J; 1975 Jul; 16(4):361-76. PubMed ID: 1152293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of various drugs on aorto-coronary vein bypass flow.
    Bertranou E; Ekeström S; Ramponi R
    Scand J Thorac Cardiovasc Surg; 1973; 7(2):161-6. PubMed ID: 4270722
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effect of intravenous dipyridamole and sublingual nitroglycerin on coronary hemodynamics and myocardial metabolism at rest and during atrial pacing in patients with coronary artery disease.
    Arrotti J; Gunnar RM; Ward J; Loeb HS
    Clin Cardiol; 1980 Dec; 3(6):365-70. PubMed ID: 6780257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitroglycerin and dipyridamole on cardiac metabolism and dynamics in a new experimental model of angina pectoris.
    Szekeres L; Csik V; Udvary E
    J Pharmacol Exp Ther; 1976 Jan; 196(1):15-28. PubMed ID: 812980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Per- and postoperative blood flow studies on aorto-coronary vein grafts in man.
    Ekeström S; Bertranou E; Giraudo N; Pérez Day C; Ramponi R; Silva Iribarren C
    Scand J Thorac Cardiovasc Surg; 1973; 7(2):149-60. PubMed ID: 4270721
    [No Abstract]   [Full Text] [Related]  

  • 6. Central haemodynamics during oxygen breathing in angina pectoris.
    Lecerof H
    Thorax; 1974 Nov; 29(6):673-7. PubMed ID: 4450176
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of midazolam on the coronary circulation in patients with coronary artery disease.
    Marty J; Nitenberg A; Blanchet F; Zouioueche S; Desmonts JM
    Anesthesiology; 1986 Feb; 64(2):206-10. PubMed ID: 2936281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of atrial pacing and dipyridamole administration on coronary hemodynamics of collateralized myocardial regions in stable angina pectoris.
    De Servi S; Ferrario M; Ghio S; Angoli L; Bramucci E; Ardissino D; Specchia G
    Am J Cardiol; 1990 Mar; 65(11):703-8. PubMed ID: 2316450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary flow and resistance reserve in patients with chronic aortic regurgitation, angina pectoris and normal coronary arteries.
    Nitenberg A; Foult JM; Antony I; Blanchet F; Rahali M
    J Am Coll Cardiol; 1988 Mar; 11(3):478-86. PubMed ID: 3278034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited coronary flow reserve after dipyridamole in patients with ergonovine-induced coronary vasoconstriction.
    Cannon RO; Schenke WH; Leon MB; Rosing DR; Urqhart J; Epstein SE
    Circulation; 1987 Jan; 75(1):163-74. PubMed ID: 3791602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic effects of dipyridamole (Persantin) following beta-blockade in coronary failure].
    Kinsbergen M; Friedemann M
    Schweiz Med Wochenschr; 1973 Feb; 103(8):312-5. PubMed ID: 4144418
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic and coronary haemodynamic effects of ketamine in intact anaesthetized and unanaesthetized dogs.
    Folts JD; Afonso S; Rowe GG
    Br J Anaesth; 1975 Jun; 47(6):686-94. PubMed ID: 1148088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oral dipyridamole on coronary dynamics and myocardial metabolism at rest and during pacing-induced angina in patients with coronary artery disease.
    Loeb HS; Danoviz J; Miller A; Gunnar RM
    Am Heart J; 1983 Jun; 105(6):906-10. PubMed ID: 6858836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nitroglycerin and dipyridamole on regional left ventricular blood flow during coronary artery occlusion.
    Becker LC
    J Clin Invest; 1976 Dec; 58(6):1287-96. PubMed ID: 825534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain.
    Cannon RO; Cunnion RE; Parrillo JE; Palmeri ST; Tucker EE; Schenke WH; Epstein SE
    J Am Coll Cardiol; 1987 Dec; 10(6):1190-200. PubMed ID: 3680786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intravenous dipyridamole on regional coronary blood flow with 1-vessel coronary artery disease: evidence against coronary steal.
    Marchant E; Pichard AD; Casanegra P; Lindsay J
    Am J Cardiol; 1984 Mar; 53(6):718-21. PubMed ID: 6702619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy.
    Nitenberg A; Foult JM; Blanchet F; Zouioueche S
    Am J Cardiol; 1985 Mar; 55(6):748-54. PubMed ID: 3976520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of monitoring techniques: coronary sinus blood flow monitoring.
    Specchia G; De Servi S; Poma E; Ghio S; Ferrario M; Angoli L; Ardissino D; Bramucci E; Mussini A
    Can J Cardiol; 1986 Jul; Suppl A():170A-172A. PubMed ID: 3756582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional coronary hemodynamics during isoflurane-nitrous oxide anesthesia in patients with ischemic heart disease.
    Reiz S; Ostman M
    Anesth Analg; 1985 Jun; 64(6):570-6. PubMed ID: 4003774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous dipyridamole-induced myocardial ischemia during percutaneous transluminal coronary angioplasty in humans.
    Klein AL; Marquis JF; Higginson LA; Morton BC; Williams WL; Davies RA; Beanlands DS
    Am J Cardiol; 1989 Feb; 63(7):419-22. PubMed ID: 2521767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.